Octav Cristea1, Daniel Yanko2, Sarah Felbel2, Andrew House3, Alp Sener4, Patrick P W Luke4. 1. Schulich School of Medicine & Dentistry, Western University, London, ON; 2. Department of Surgery, Division of Urology, Western University, London, ON; 3. Department of Medicine, Division of Nephrology, Western University, London, ON. 4. Schulich School of Medicine & Dentistry, Western University, London, ON; ; Department of Surgery, Division of Urology, Western University, London, ON; ; Multi-Organ Transplant Program, London Health Sciences Centre, Western University, London, ON; ; Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, Western University, London, ON;
Abstract
INTRODUCTION: Native nephrectomy in patients with autosomal dominant polycystic kidney disease (ADPKD) is performed on a case-by-case basis. We determine if pre-transplant maximal kidney length (MKL) can be used to predict ultimate nephrectomy status. METHODS: We performed a retrospective review of ADPKD patients who underwent renal transplantation at our centre between January 2000 and December 2012. Pre-transplant measurements of MKL alone, MKL adjusted for height (HtMKL), weight (WtMKL) and body mass index (BMI-MKL) were each assessed for their predictive ability via a receiver operating characteristic (ROC) curve analysis. RESULTS: In total, 84 patients met our inclusion criteria, of which 17 (20.2%) underwent native nephrectomy. An MKL ROC curve analysis revealed an area under the curve (AUC) of 0.867 (95% confidence interval [CI] 0.775-0.931; p < 0.001). An optimal cutoff criterion of >21.5 cm revealed a sensitivity of 94.1% (95% CI 71.3-99.9) and specificity of 70.1% (95% CI 57.7-80.7) for eventual nephrectomy. The AUC of HtMKL, WtMKL and BMI-MKL ROC curves did not differ significantly from MKL alone. HtMKL improved specificity, but not overall test performance. The determination of the cut-off MKL may be influenced by the single-centre retrospective nature of this analysis, as well as the fact that renal size was determined by ultrasound and not computerized tomography or magnetic resonance imaging. CONCLUSION: MKL in patients with ADPKD is associated with the eventual need for nephrectomy and may be a useful clinical tool to risk stratify these patients and therefore guide patient conversations to a decision to leave the native kidneys in situ.
INTRODUCTION: Native nephrectomy in patients with autosomal dominant polycystic kidney disease (ADPKD) is performed on a case-by-case basis. We determine if pre-transplant maximal kidney length (MKL) can be used to predict ultimate nephrectomy status. METHODS: We performed a retrospective review of ADPKDpatients who underwent renal transplantation at our centre between January 2000 and December 2012. Pre-transplant measurements of MKL alone, MKL adjusted for height (HtMKL), weight (WtMKL) and body mass index (BMI-MKL) were each assessed for their predictive ability via a receiver operating characteristic (ROC) curve analysis. RESULTS: In total, 84 patients met our inclusion criteria, of which 17 (20.2%) underwent native nephrectomy. An MKL ROC curve analysis revealed an area under the curve (AUC) of 0.867 (95% confidence interval [CI] 0.775-0.931; p < 0.001). An optimal cutoff criterion of >21.5 cm revealed a sensitivity of 94.1% (95% CI 71.3-99.9) and specificity of 70.1% (95% CI 57.7-80.7) for eventual nephrectomy. The AUC of HtMKL, WtMKL and BMI-MKL ROC curves did not differ significantly from MKL alone. HtMKL improved specificity, but not overall test performance. The determination of the cut-off MKL may be influenced by the single-centre retrospective nature of this analysis, as well as the fact that renal size was determined by ultrasound and not computerized tomography or magnetic resonance imaging. CONCLUSION: MKL in patients with ADPKD is associated with the eventual need for nephrectomy and may be a useful clinical tool to risk stratify these patients and therefore guide patient conversations to a decision to leave the native kidneys in situ.
Authors: Jared J Grantham; Vicente E Torres; Arlene B Chapman; Lisa M Guay-Woodford; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Phillip J Kenney; Peter C Harris; Saulo Klahr; William M Bennett; Gladys N Hirschman; Catherine M Meyers; Xiaoling Zhang; Fang Zhu; John P Miller Journal: N Engl J Med Date: 2006-05-18 Impact factor: 91.245
Authors: W Charles O'Neill; Michelle L Robbin; Kyongtae T Bae; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Vicente E Torres; Bernard F King; Louis H Wetzel; Paul A Thompson; J Philip Miller Journal: Am J Kidney Dis Date: 2005-12 Impact factor: 8.860
Authors: J J Grantham; L T Cook; V E Torres; J E Bost; A B Chapman; P C Harris; L M Guay-Woodford; K T Bae Journal: Kidney Int Date: 2007-10-24 Impact factor: 10.612
Authors: D Cohen; M-O Timsit; Y Chrétien; N Thiounn; V Vassiliu; M-F Mamzer; C Legendre; A Méjean Journal: Prog Urol Date: 2008-09-14 Impact factor: 0.915
Authors: Perditer Okyere; Richard K D Ephraim; Isaac Okyere; Joseph Attakorah; Dorcas Serwaa; Grace Essuman; Albert Abaka-Yawson; Prince Adoba Journal: BMC Nephrol Date: 2021-04-28 Impact factor: 2.388